Pure Global
NCT05925075

Lung Ultrasound in Preterm Infants

Point of Care Lung Ultrasound in Preterm Infants With Respiratory Distress: A Multicenter Prospective Study
Phoenix Children's Hospital·ClinicalTrials.gov·diagnostic testEnrolling by invitation
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Bronchopulmonary Dysplasia
Drug/Device/Intervention
Lung Ultrasound
Study type
Observational
Intervention type
diagnostic test
Sponsor & location
Primary sponsor
Phoenix Children's Hospital
Location
Phoenix, United States of America
Timeline & enrollment
Phase
N/A
Start date
Apr 17, 2023
End date
Apr 01, 2025
Enrollment
150 participants
Primary outcome

Assess predictive ability of lung ultrasound scores in infants at risk of developing bronchopulmonary dysplasia (BPD)

Summary

The goal of this observational study is to learn about the role of bedside lung ultrasound in
 infants born prematurely with breathing problems. The main question this study aims to answer
 is: Can bedside lung ultrasound performed in the first month of life predict the development
 of chronic lung disease in premature infants?

ICD-10 classifications
Bronchopulmonary dysplasia originating in the perinatal periodCongenital bronchomalaciaBronchopneumonia, unspecifiedOther congenital malformations of bronchusDiseases of bronchus, not elsewhere classified
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05925075
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT05925075 through Pure Global AI's free database. This phase not specified trial is sponsored by Phoenix Children's Hospital and is currently Enrolling by invitation. The study focuses on Bronchopulmonary Dysplasia. Target enrollment is 150 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.